Core trisomies
Trisomies 13, 18 and 21
NIPT TESTS & PRICING
Compare the four currently listed plans by scope, price and limitations.
All plans include screening for trisomies 13, 18 and 21. Plans B, C and D add different combinations of sex chromosomes, fetal sex, whole-chromosome analysis, SMA, fragile X syndrome and selected microdeletions.

Trisomies 13, 18 and 21
Core trisomies + sex chromosomes + fetal sex + whole-chromosome analysis
Plan B + SMA and fragile X (confirm purpose and method separately)
Core trisomies + whole-chromosome analysis + fetal sex + selected microdeletions
Listed prices are tax-inclusive test fees. Before proceeding, confirm the total, cancellation and refund terms, and whether consultations, genetic counselling, home collection, repeat collection and diagnostic follow-up cost extra. More items do not necessarily make a plan more suitable.
SMA and fragile X tests have a different purpose from NIPT. Confirm who is tested, the specimen, method and limitations separately. ‘Confirm’ marks scope not yet confirmed.
| Test item | Plan A | Plan B | Plan C | Plan D |
|---|---|---|---|---|
| Trisomies 13, 18 and 21 | ●Included | ●Included | ●Included | ●Included |
| Sex chromosome analysis | —Not included | ●Included | ●Included | Confirm |
| Fetal sex | —Not included | ●Included | ●Included | ●Included |
| Whole-chromosome analysis | —Not included | ●Included | ●Included | ●Included |
| Spinal muscular atrophy (SMA) | —Not included | —Not included | ●Included | —Not included |
| Fragile X syndrome | —Not included | —Not included | ●Included | —Not included |
| Selected microdeletions | —Not included | —Not included | —Not included | ●Included |
TEST SCOPE
Each plan separates the conditions screened from information outside its scope.
Estimates the chance of trisomy 13 (Patau syndrome), trisomy 18 (Edwards syndrome) and trisomy 21 (Down syndrome).
Screens for selected numerical sex-chromosome differences, including patterns associated with Turner, Klinefelter and triple X syndromes.
Whole-chromosome analysis does not detect every abnormality. Confirm analysis and reporting scope with your provider, especially sex-chromosome reporting in Plan D.
Selected regions are explained according to the plan. Refer to the pre-test information for the current scope.
These differ from NIPT in purpose, specimen and interpretation. Confirm genes, method, price and eligibility separately.
NIPT does not assess every congenital condition, structural difference, developmental outcome or future health state.
PROCESS
SGH explains plans, prices and areas. Discuss eligibility and genetic counselling with your medical provider.
Visit a partner provider, or use nurse home collection when a participating provider can arrange it, then provide about 10 ml of blood after the required consultation and consent.
Review the information about GenePhile Bioscience Laboratory at 柯滄銘婦產科診所 and confirm the commissioned scope with your provider before testing.
10–14 days after receipt in Taiwan is an estimate. Your medical provider handles results, genetic counselling and any follow-up testing discussion.
LIMITATIONS
FAQ
Consultation, blood collection, diagnostic testing or repeat sampling may involve separate charges. Confirm the total when booking.
The plans differ in whether they include sex chromosomes, whole-chromosome analysis, selected inherited conditions or selected microdeletions.
SOURCES
CONSULTATION
We can review scope, price and eligibility with you.